DNTH — Dianthus Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapMomentum Trap

Annual balance sheet for Dianthus Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	177	112	174	275	404
Net Total Accounts Receivable
Net Total Receivables	—	—	0.478	0.807	0.052
Prepaid Expenses
Total Other Current Assets
Total Current Assets	181	116	177	281	409
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	7.46	29.3	0.8	1.75	1.63
Long Term Investments
Other Long Term Assets
Total Assets	190	147	179	374	531
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	10.9	14.5	9.63	18.5	30.7
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	17.3	40.7	10.5	21.5	37.5
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	173	106	169	352	493
Total Liabilities & Shareholders' Equity	190	147	179	374	531
Total Common Shares Outstanding